{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:17:29Z","timestamp":1790705849506,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.yrtph.2021.105021","type":"journal-article","created":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T09:19:19Z","timestamp":1627809559000},"page":"105021","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["AOP and IATA applied to ocular surface toxicity"],"prefix":"10.1016","volume":"125","author":[{"given":"No\u00e9mie","family":"Bonneau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1743-6698","authenticated-orcid":false,"given":"Christophe","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Brignole-Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2021.105021_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cbpa.2017.06.002","article-title":"Lipid homeostasis and regulated cell death","volume":"39","author":"Agmon","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"41","key":"10.1016\/j.yrtph.2021.105021_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/15321819.2020.1726774","article-title":"Biomarkers of inflammation and oxidative stress in ophthalmic disorders","volume":"3","author":"Ahmad","year":"2020","journal-title":"J. Immunoassay Immunochem."},{"issue":"11","key":"10.1016\/j.yrtph.2021.105021_bib8","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/cne.24454","article-title":"Morphological and functional changes in TRPM8-expressing corneal cold thermoreceptor neurons during aging and their impact on tearing in mice","volume":"526","author":"Alcalde","year":"2018","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.yrtph.2021.105021_bib9","first-page":"11","article-title":"The three Rs of Russell & Burch and the testing of biological products","volume":"86","author":"Balls","year":"1996","journal-title":"Dev. Biol. Stand."},{"issue":"3","key":"10.1016\/j.yrtph.2021.105021_bib10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0161-6420(99)90116-1","article-title":"Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies","volume":"106","author":"Baudouin","year":"1999","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.yrtph.2021.105021_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","article-title":"Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction","volume":"100","author":"Baudouin","year":"2016","journal-title":"Br J Ophtalmol"},{"key":"10.1016\/j.yrtph.2021.105021_bib12","first-page":"100916","article-title":"Inflammation in Glaucoma: from the back to the front of the eye, and beyond","volume":"17","author":"Baudouin","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"issue":"11","key":"10.1016\/j.yrtph.2021.105021_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050180","article-title":"A new safety concern for glaucoma treatment demonstrated by mass spectrometry imaging of benzalkonium chloride distribution in the eye, an experimental study in rabbits","volume":"7","author":"Brignole-Baudouin","year":"2012","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.yrtph.2021.105021_bib14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul. Surf."},{"issue":"1","key":"10.1016\/j.yrtph.2021.105021_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08830185.2012.750138","article-title":"In This issue: immunology of the eye-inside and out","volume":"32","author":"Caspi","year":"2013","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.yrtph.2021.105021_bib16","first-page":"851","article-title":"Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro","volume":"18","author":"Clouzeau","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.yrtph.2021.105021_bib17","doi-asserted-by":"crossref","first-page":"104663","DOI":"10.1016\/j.yrtph.2020.104663","article-title":"Chronic inflammation, Adverse Outcome Pathways, and risk assessment: a diagrammatic exposition","volume":"114","author":"Cox","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.yrtph.2021.105021_bib18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul. Surf."},{"issue":"4","key":"10.1016\/j.yrtph.2021.105021_bib19","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1167\/iovs.16-20903","article-title":"The eye drop preservative benzalkonium chloride potently induces mitochondrial dysfunction and preferentially affects LHON mutant cells","volume":"58","author":"Datta","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.yrtph.2021.105021_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.fct.2004.09.004","article-title":"Eye irritation of low-irritant cosmetic formulations: correlation of in vitro results with clinical data and product composition","volume":"43","author":"Debbasch","year":"2005","journal-title":"Food Chem. Toxicol."},{"issue":"6","key":"10.1016\/j.yrtph.2021.105021_bib21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/mi.2012.43","article-title":"CX3CL1 expression in the conjunctiva is involved in immune cell trafficking during toxic ocular surface inflammation","volume":"5","author":"Denoyer","year":"2012","journal-title":"Mucosal Immunol."},{"issue":"7","key":"10.1016\/j.yrtph.2021.105021_bib22","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1111\/jcmm.14975","article-title":"Endogenous ocular lipids as potential modulators of intraocular pressure","volume":"24","author":"Edwards","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.yrtph.2021.105021_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jtos.2017.05.004","article-title":"TFOS DEWS II iatrogenic report","volume":"15","author":"Gomes","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.yrtph.2021.105021_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-3-030-21162-2_8","article-title":"Inflammatory ocular diseases and sphingolipid signaling","volume":"1159","author":"Grambergs","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.yrtph.2021.105021_bib25","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ajo.2006.06.052","article-title":"Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study (OHTS)","volume":"142","author":"Herman","year":"2006","journal-title":"Am J ophtalmol"},{"issue":"5","key":"10.1016\/j.yrtph.2021.105021_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/jop.2006.0067","article-title":"The etiology of steroid cataract","volume":"23","author":"James","year":"2007","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"2","key":"10.1016\/j.yrtph.2021.105021_bib27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/toxsci\/kfu234","article-title":"FutureTox II: in vitro data and in silico models for predictive toxicology","volume":"143","author":"Knudsen","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2021.105021_bib28","doi-asserted-by":"crossref","first-page":"104713","DOI":"10.1016\/j.yrtph.2020.104713","article-title":"Replacing the refinement for skin sensitization testing: considerations to the implementation of adverse outcome pathway (AOP)-based defined approaches (DA) in OECD guidelines","volume":"115","author":"Kolle","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.yrtph.2021.105021_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/toxsci\/59.2.335","article-title":"Prediction of eye irritation from organic chemicals using membrane-interaction QSAR analysis","volume":"59","author":"Kulkarni","year":"2001","journal-title":"Toxicol. Sci."},{"issue":"9","key":"10.1016\/j.yrtph.2021.105021_bib30","doi-asserted-by":"crossref","first-page":"994e9","DOI":"10.1097\/ICO.0b013e31823f8cb6","article-title":"Tear film osmolarity in patients treated for glaucoma or ocular hypertension","volume":"31","author":"Labb\u00e9","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.yrtph.2021.105021_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nbd.2015.12.017","article-title":"Ocular inflammation induces trigeminal pain, peripheral and central neuroinflammatory mechanisms","volume":"88","author":"Launay","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.yrtph.2021.105021_bib32","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1038\/s41598-017-06369-8","article-title":"An in vitro model for the ocular surface and tear film system","volume":"7","author":"Lu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yrtph.2021.105021_bib33","doi-asserted-by":"crossref","first-page":"104717","DOI":"10.1016\/j.yrtph.2020.104717","article-title":"Human health hazard assessment of quaternary ammonium compounds: didecyl dimethyl ammonium chloride and alkyl (C12-C16) dimethyl benzyl ammonium chloride","volume":"116","author":"Luz","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2021.105021_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.biochi.2020.07.015","article-title":"Lipidomic analysis of human corneal epithelial cells exposed to ocular irritants highlights the role of phospholipid and sphingolipid metabolisms in detergent toxicity mechanisms","volume":"178","author":"Magny","year":"2020","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.yrtph.2021.105021_bib35","first-page":"572","article-title":"Activation of TRPA1 by volatile organic chemicals leading to sensory irritation","volume":"36","author":"Martinez","year":"2019","journal-title":"ALTEX"},{"issue":"9","key":"10.1016\/j.yrtph.2021.105021_bib36","doi-asserted-by":"crossref","first-page":"5154","DOI":"10.1167\/iovs.12-9685","article-title":"Toxicity evaluation of antiglaucoma drugs using stratified human cultivated corneal epithelial sheets","volume":"53","author":"Nakagawa","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.yrtph.2021.105021_bib1","series-title":"Guidance Document on Developing and Assessing Adverse Out-Come Pathways, Series on Testing and Assessment, No 184 (ENV\/JM\/MONO(2013)6)","year":"2013"},{"key":"10.1016\/j.yrtph.2021.105021_bib2","series-title":"OECD Series on Adverse Outcome Pathwways","year":"2015"},{"key":"10.1016\/j.yrtph.2021.105021_bib3","series-title":"Webinar Series on Testing and Assessment Methodologies: Adverse Outcome Pathway (AOP) Framework","year":"2019"},{"key":"10.1016\/j.yrtph.2021.105021_bib4","series-title":"Adverse Outcome Pathways, Molecular Screening and Toxicogenomics","year":"2020"},{"key":"10.1016\/j.yrtph.2021.105021_bib5","series-title":"The OECD QSAR Toolbox","year":"2020"},{"key":"10.1016\/j.yrtph.2021.105021_bib37","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.compbiomed.2017.11.009","article-title":"Computational modeling of drug transport across the in vitro cornea","volume":"92","author":"Pak","year":"2018","journal-title":"Comput. Biol. Med."},{"issue":"12","key":"10.1016\/j.yrtph.2021.105021_bib38","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1167\/iovs.06-0728","article-title":"New tools for the evaluation of toxic ocular surface changes in the rat","volume":"48","author":"Pauly","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.yrtph.2021.105021_bib39","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1167\/iovs.08-2992","article-title":"Multiple endpoint analysis of the 3D-Reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage","volume":"50","author":"Pauly","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.yrtph.2021.105021_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5005\/jp-journals-10028-1226","article-title":"Steroid-induced Glaucoma: an avoidable irreversible blindness","volume":"11","author":"Phulke","year":"2017","journal-title":"J. Curr. Glaucoma Pract."},{"issue":"4","key":"10.1016\/j.yrtph.2021.105021_bib41","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","article-title":"Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication","volume":"86","author":"Pisella","year":"2002","journal-title":"Br. J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.yrtph.2021.105021_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201740","article-title":"Tear biomarkers in latanoprost and bimatoprost treated eyes","volume":"13","author":"Reddy","year":"2018","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.yrtph.2021.105021_bib43","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1167\/iovs.11-8775","article-title":"Corneal neurotoxicity due to topical benzalkonium chloride","volume":"53","author":"Sarkar","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.yrtph.2021.105021_bib44","first-page":"56308","article-title":"Corneal tissue engineering: an in vitro model of the stromal-nerve interactions of the human cornea","volume":"131","author":"Sharif","year":"2018","journal-title":"JoVE"},{"issue":"12","key":"10.1016\/j.yrtph.2021.105021_bib45","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1096\/fasebj.9.12.7672510","article-title":"Oxidative stress-induced cataract: mechanism of action","volume":"9","author":"Spector","year":"1995","journal-title":"Faseb. J."},{"issue":"11","key":"10.1016\/j.yrtph.2021.105021_bib46","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/bjophthalmol-2017-311544","article-title":"Preservatives in glaucoma medication","volume":"102","author":"Steven","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.yrtph.2021.105021_bib47","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.toxlet.2019.10.014","article-title":"Benzalkonium chloride-induced direct and indirect toxicity on corneal epithelial and trigeminal neuronal cells: proinflammatory and apoptotic responses in vitro","volume":"319","author":"Vitoux","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2021.105021_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2016.09.030","article-title":"In vitro 3D corneal tissue model with epithelium, stroma, and innervation","volume":"112","author":"Wang","year":"2017","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.yrtph.2021.105021_bib49","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad pathways in TGF-\u03b2 signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.yrtph.2021.105021_bib50","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jtos.2019.11.006","article-title":"Dose-dependent benzalkonium chloride toxicity imparts ocular surface epithelial changes with features of dry eye disease","volume":"18","author":"Zhang","year":"2020","journal-title":"Ocul. Surf."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230021001628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230021001628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:32:52Z","timestamp":1759494772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230021001628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":50,"alternative-id":["S0273230021001628"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2021.105021","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AOP and IATA applied to ocular surface toxicity","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2021.105021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105021"}}